deepCDR Biologics

Basel, Switzerland Founded: 2019 • Age: 7 yrs Acquired By Alloy Therapeutics
Diagnostic and pharmaceutical products are manufactured by deepCDR Biologics.
Request Access

About deepCDR Biologics

deepCDR Biologics is a company based in Basel (Switzerland) founded in 2019 by Sai Reddy was acquired by Alloy Therapeutics in December 2021.. deepCDR Biologics operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.

  • Headquarter Basel, Switzerland
  • Founders Sai Reddy
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Alloy Therapeutics

    (Dec 09, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of deepCDR Biologics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in deepCDR Biologics

deepCDR Biologics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alloy Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided for therapeutic development.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by deepCDR Biologics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - deepCDR Biologics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Deepcdr Biologics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of deepCDR Biologics

deepCDR Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cloud-based protein-modeling software is developed for drug discovery.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
Proteomics platform developed for early cancer and neurological disease detection.
domain founded_year HQ Location
Proteomics services are delivered via discovery and targeted platforms.
domain founded_year HQ Location
Provider tools to help researchers with protein analysis
domain founded_year HQ Location
Small molecule oncology therapeutics are developed for cancer treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Deepcdr Biologics

Frequently Asked Questions about deepCDR Biologics

When was deepCDR Biologics founded?

deepCDR Biologics was founded in 2019.

Where is deepCDR Biologics located?

deepCDR Biologics is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

What does deepCDR Biologics do?

deepCDR Biologics was founded in 2019 in Basel, Switzerland, with Sai Reddy serving as co-founder. Diagnostic and pharmaceutical products are developed and produced by the company within the biologics sector. Operations are centered on healthcare applications, including testing and treatment solutions. The focus remains on manufacturing processes tailored to medical needs, supported by a presence in the European pharmaceutical landscape.

Who are the top competitors of deepCDR Biologics?

deepCDR Biologics's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.

Who are deepCDR Biologics's investors?

deepCDR Biologics has 1 investor. Key investors include Alloy Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available